A Modern Approach to the Correction of Lipid Metabolism in Kidney Disease

Authors

  • Khojiyeva Nozima Shuxratovna Bukhara State Medical Institute, Bukhara, Uzbekistan

Keywords:

chronic kidney disease, cholesterol, triglycerides, low density lipoproteins, high density lipoproteins, apo AI, apo AII, lipoprotein lipase, hepatic triglyceride lipase, statins, fibrates, nicotinic acid

Abstract

Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid modifying drugs — statins, fibrates, nicotinic acid was proposed.

Downloads

Published

2022-10-13

How to Cite

Shuxratovna, K. N. (2022). A Modern Approach to the Correction of Lipid Metabolism in Kidney Disease. Procedia of Engineering and Medical Sciences, 10–16. Retrieved from https://procedia.online/index.php/engineering/article/view/198